Oncoclínicas sold its Saudi oncology venture for US$6.5 million, a small divestment that signals a wider deleveraging push at the Brazilian cancer-care.

Oncoclínicas sold its Saudi oncology venture for US$6.5 million, a small divestment that signals a wider deleveraging push at the Brazilian cancer-care.

Oncoclínicas files for extrajudicial recovery to restructure R$5.1 billion in debt as long-time backer Goldman Sachs sells its stake after 11 years.